Journal profile · Materials Science, Biomaterials
Acta Biomaterialia
ISSN 1742-7061 · eISSN 1878-7568 · Elsevier BV · ENGLAND · Bimonthly · Founded 2005
Acta Biomaterialia: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 10.37; hybrid open access; APC about USD 3,810; median 120 days to acceptance (150 articles, last 24 months); community-reported acceptance: fairly hard; 765 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Acta Biomaterialia is published by Elsevier BV and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Bone Tissue Engineering Materials, Electrospun Nanofibers in Biomedical Applications and 3D Printing in Biomedical Research, together about 31.6% of its articles. Its main subfields are Biomedical Engineering. (generated from OpenAlex topic counts and CAS ranking data)
Browse through a wide range of high-quality academic journals offered by Elsevier, including open access options, to enrich your research journey.
From the journal's Aims & Scope
Research area (LetPub): Materials Science, Biomaterials
Main research topics OpenAlex counts of recent articles; shares are approximate
- Bone Tissue Engineering MaterialsEngineering15.8%
- Electrospun Nanofibers in Biomedical ApplicationsMaterials Science8.6%
- 3D Printing in Biomedical ResearchEngineering7.2%
- Nanoplatforms for cancer theranosticsEngineering6.3%
- Tissue Engineering and Regenerative MedicineMedicine6%
- Nanoparticle-Based Drug DeliveryMaterials Science4.3%
- Orthopaedic implants and arthroplastyMedicine4.3%
- Cellular Mechanics and InteractionsBiochemistry, Genetics and Molecular Biology3.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Engineering, Biomedical | Zone 1 |
| Minor | Materials Science, Biomaterials | Zone 1 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Engineering, Biomedical | Zone 1 |
| Minor | Materials Science, Biomaterials | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Engineering, Biomedical | Zone 1 |
| Minor | Materials Science, Biomaterials | Zone 1 |
Top journal: yesReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 10.37LetPub ·
- CiteScore 2026-06
- 17.7LetPub ·
- SJR 2026-06
- 1.88LetPub ·
- SNIP 2026-06
- 1.59LetPub ·
- h-index
- 155LetPub ·
- h-index
- 298OpenAlex ·
- i10-index
- 9,168OpenAlex ·
- 2-year mean citedness
- 9.31OpenAlex ·
- Self-citation rate
- 2.9%LetPub ·
- Share of gold OA articles
- 28.75%LetPub ·
Volume
- Articles per year
- 694LetPub ·
Articles by year OpenAlex count · 11,310 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 528 | 209 | 394 |
| 2025 | 765 | 325 | 5,836 |
| 2024 | 622 | 298 | 11,601 |
| 2023 | 641 | 264 | 17,786 |
| 2022 | 730 | 280 | 30,228 |
| 2021 | 704 | 316 | 36,541 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
120 daysMedian, submission to acceptance · P25–P75 100 days – 149 days
- Acceptance to online
- median 1 days (150 articles)
- Submission to online
- median 121 days
- Sample
- 150 articles with submission and acceptance dates (1,487 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 2.8 monthsLetPub ·
- Average acceptance (community reports)
- Fairly hardLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,810 / EUR 3,560 / GBP 3,050 / JPY 472,550 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Elsevier BV
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Bimonthly
- Founded
- 2005
- ISSN
- 1742-7061
- Electronic ISSN
- 1878-7568
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Acta Biomaterialia
What CAS zone is Acta Biomaterialia in?
In the 2025 upgraded edition of the CAS Journal Ranking, Acta Biomaterialia is in Zone 1 of Medicine, and in Zone 1 of the minor category Engineering, Biomedical / Materials Science, Biomaterials; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Acta Biomaterialia?
The latest impact factor listed by LetPub is 10.37; CiteScore 17.7, h-index 298.
How long does peer review take at Acta Biomaterialia?
Based on the dates recorded on 150 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 120 days (interquartile range 100–149 days); authors report an average review time of about 2.8 months; the community-reported acceptance is “Fairly hard”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Acta Biomaterialia?
According to LetPub and DOAJ records, Acta Biomaterialia is indexed in SCIE and Scopus.
Is Acta Biomaterialia open access, and what is the APC?
Acta Biomaterialia is a hybrid journal. For open-access publication: APC about USD 3,810.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .